Skip to content

Development and application of a decision aid for intravenous thrombolysis in acute ischemic stroke patients based on the Ottawa decision support framework

Development and application of a decision aid for intravenous thrombolysis in acute ischemic stroke patients based on the Ottawa decision support framework

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2400083453
Enrollment
Unknown
Registered
2024-04-25
Start date
2024-05-01
Completion date
Unknown
Last updated
2024-04-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

acute ischemic stroke

Interventions

Intervention group:Decision Aid for Intravenous Thrombolysis
Control group:Routine Nursing Care Education

Sponsors

The Second Affiliated Hospital of Soochow University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: Patients inclusion criteria: ? Age =18 years old; ? Meet the diagnostic criteria of China Acute Ischemic Stroke Diagnostic and Treatment Guidelines 2018, and diagnosed by cranial CT and/or MRI; ? Within the time window of intravenous thrombolysis, the patient meets the indications for thrombolysis after evaluation by the physician; ? Condition is stable, clear consciousness, normal communication, cognitive judgment, and no history of serious psychiatric illness; ? Patient or surrogate decision-maker Participate in the intravenous thrombolysis informed consent conversation and sign the intravenous thrombolysis informed consent form; ? Participate voluntarily, give informed consent to this study and sign the informed consent form. Surrogate decision-makers inclusion criteria: ? Age = 18 years, must be immediate family members (parents, spouse, children, or family members who have signed the power of attorney with the patient's consent); ? Participate in the intravenous thrombolysis informed consent interview and sign the intravenous thrombolysis informed consent form on behalf of the patient; ? Consciousness, can be communicated normally, with the ability to make cognitive judgments, no history of serious mental illness; ? Participate voluntarily, give informed consent to the study, and sign the informed consent form. (iv) Voluntary participation, informed consent to the study, and signing the informed consent form.

Exclusion criteria

Exclusion criteria: patients exclusion criteria: ?patients with severe functional disorders of heart, brain, kidney and other organs, cognitive dysfunction or psychiatric illnesses who could not cooperate with the study; ?patients who were referred to our hospital for intravenous thrombolysis after the onset of the disease by other medical institutions; ?patients who were not accompanied by emergency stroke nurses or were not accompanied by them throughout the whole process; ? patients who voluntarily withdrew from the study in the course of the study. Surrogate decision-makers exclusion criteria: ? unable to participate due to visual, hearing impairment, cognitive impairment; ? voluntarily withdrew from the study during the course of the study.

Design outcomes

Primary

MeasureTime frame
Obtain informed consent time;Decision conflict;

Secondary

MeasureTime frame
Patient satisfaction with treatment decisions;Door to needle time(DNT);DNT<45 minute ratio;DNT<60 minute ratio;

Countries

China

Contacts

Public ContactTan LIping

The Second Affiliated Hospital of Soochow University

tlping67@126.com+86 139 6251 4643

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026